Pharmaceutical Products Tenders & Contracts

The Agency requires a dependable supply of Specific Pathogen Free (SPF) eggs for scientific and biological research. The current supply originates from the United States of America (USA). To improve resilience, mitigate supply risks and diversify the geographical origin of supply, the Agency is seeking bids under this tender for SPF eggs sourced from outside the USA.

The North East & Yorkshire NHS Pharmaceutical Purchasing Consortium (NEYPPC) intend to establish a Framework Agreement for the provision of High Tech Homecare Medicines Services. The scope of this procurement will encompass all High Tech Homecare Medicines Services required by member Trusts within the NEY region, while also allowing access for non-member Trusts. Access for non-member Trusts will be available to any publicly funded entity, subject to prior approval from the Authority. The expectation is that the Framework will be multi-award, structured into the following Lots: Lot HT26-A: Unlicensed Compounded Desferrioxamine Homecare Medicines Services Lot HT26-B: Unlicensed Compounded Antimicrobial Homecare Medicines Services Lot HT26-C: Unlicensed Compounded Chemotherapy and Monoclonal Antibody Homecare Medicines Services Lot HT26-D: Other Unlicensed Compounded Homecare Medicines Services Lot HT26-E: Metabolic Disorders Homecare Medicines Services Medicines Lot HT26-F: Other Non-compounded High Tech Homecare Medicines Services

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.

The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for its members the supply of Adult and Paediatric Nutrition products as defined in this specification. This procurement exercise is being carried out as an Open Procedure under the PA23 Regulations. The Framework will run for an initial two (2) Year period with an option to extend for a further two (2) Years. (2 + 2 - maximum duration Four (4) Years)

The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for its members the supply of Adult and Paediatric Nutrition products as defined in this specification. This procurement exercise is being carried out as an Open Procedure under the PA23 Regulations. The Framework will run for an initial two (2) Year period with an option to extend for a further two (2) Years. (2 + 2 - maximum duration Four (4) Years)

Supply of Seasonal Influenza Vaccine.

Suffolk County Council (Public Health, Communities and Public Safety) are currently out to tender for the postal supply of Nicotine Replacement Therapy (NRT) and smoking cessation prescription medication. Smoking prevalence in Suffolk is currently estimated at 10.5%. The Council's ambition is to reduce this to 5% or below by 2030. NRT and prescribed smoking cessation medications are recognised as effective interventions to support people to quit smoking and remain an important element of the local stop smoking offer. The Council currently provides access to these products through a pharmacy-based pathway. However, not all clients are able to access participating pharmacies due to factors such as working hours, limited transport options or mobility issues. The Council is therefore exploring alternative delivery models to improve accessibility. The procurement is split into two lots. Suppliers may bid for either lot individually or for both lots. Lot 1 - Nicotine Replacement Therapy (NRT) Supply a range of NRT products following referral from the Council's commissioned stop smoking service (FGS) and deliver products directly to clients using a reliable and secure postal service. Lot 2 - Smoking cessation prescription medication Undertake remote clinical consultations with clients referred by the stop smoking service to assess suitability for Varenicline or Cytisine and, where clinically appropriate, supply medication directly to clients using a reliable and secure postal service. This opportunity is available in the 'Current Tenders' area of the portal. Interested parties are invited to express their interest to gain full access to the tender documentation. The contract period is two years with an option to extend for up to a further two years. The anticipated contract value (including the extension period) is approximately £400,000 (approximately £100,000 per annum) excluding VAT. The deadline date for submissions of the tender is 3rd November 2026 at 11am. Please note late returns will NOT be permitted. The deadline for clarification questions is 20th October 2026 which must be generated via the correspondence option on the website.

This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.

Request for quotation for an online provision including treatment and recovery of drug use.

Formalin Biopsy Pots and Associated Products